These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 806544)

  • 21. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas.
    Pross HF; Kerbel RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1157-67. PubMed ID: 1087351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractoriness of lymph-node cells from tumour-bearing animals.
    Burk MW; Yu S; Ristow SS; McKhann CF
    Int J Cancer; 1975 Jan; 15(1):99-108. PubMed ID: 47843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes and correlation of plasma immunoglobulins with tumor growth in fibrosarcoma-bearing mice.
    Saha S; Prasad AK; Ray PK
    Indian J Exp Biol; 1987 Aug; 25(8):514-8. PubMed ID: 3128475
    [No Abstract]   [Full Text] [Related]  

  • 24. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary tumor immunity in nude mice.
    Prehn LM; Outzen HC
    Int J Cancer; 1977 May; 19(5):688-91. PubMed ID: 863547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of rhabdomyosarcoma in mice C3H/He by Co 60 and hyperbaric oxygen (author's transl)].
    Agnius-Delord C; Couderc P; Laval P; Mourret A; Rinaldi R; Rinaldi C
    Bull Cancer; 1979; 66(3):211-6. PubMed ID: 486730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
    Parmiani G; Lembo R
    Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
    [No Abstract]   [Full Text] [Related]  

  • 29. [The "immunologic portrait" and tumorigenicity of neoplastic cells induced in mice by 3-methylcholanthrene].
    Iaroslavtseva OA; Viksler VKh; Lavrovskiĭ VA
    Eksp Onkol; 1988; 10(6):26-9. PubMed ID: 3243190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 31. Restoration of growth control in malignantly transformed mouse fibroblasts grown in a chemically defined medium.
    Tomei LD; Bertram JS
    Cancer Res; 1978 Feb; 38(2):444-51. PubMed ID: 620413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated growth of syngeneic tumors in mice treated with methylcholanthrene.
    Lill PH; Jessup JM; Kripke ML
    Int J Cancer; 1978 Apr; 21(4):511-5. PubMed ID: 669850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative immunoelectrophoretic study on extracts of LS fibroblasts and of tumors produced by inoculating them into C3H mice (author's transl).
    Benassi G; Berti G; Melandri P
    Tumori; 1974; 60(3):211-20. PubMed ID: 4428499
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity and immunosensitivity of SV40-transformed cells with different oncogenic potentials.
    Stillström J
    Int J Cancer; 1973 Sep; 12(2):493-501. PubMed ID: 4365094
    [No Abstract]   [Full Text] [Related]  

  • 37. Strength of the tumour-specific antigens and of the "hybrid effect" of three chemically-induced sarcomas of the same inbred strain origin.
    Oth D; Burg C
    Folia Biol (Praha); 1970; 16(6):374-80. PubMed ID: 4394677
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
    Buchsbaum DJ; Walker PC; Johnson EA
    Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological competence of spleen cells from rats bearing syngeneic or autochthonous tumours.
    Medzihradský J; Koníková E; Novotná L
    Neoplasma; 1972; 19(2):105-10. PubMed ID: 4401919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.